Program overview
Context
Indication: Resectable Pancreatic Ductal Adenocarcinoma
Mechanism: Unknown
Modality: Unknown
Sponsor: British Columbia Cancer Agency
Timeline Staleness Signal
Metformin Hydrochloride 500Mg Tablet
Metformin Hydrochloride 500Mg Tablet is flagged as timeline staleness signal because public records show timeline staleness, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 3/5
Timeline: 3/5
Recruitment burden: 2/5
Results availability: 0/5
Program risk: 4/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT02978547
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT02978547 | Unknown Status Signal (UNKNOWN) | stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal | Low Signal | rare_population_signal | strict_eligibility_signal |